14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRNX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Crinetics Pharmaceuticals Inc stock price down 2.38% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Loss -2.38% PDF

The Crinetics Pharmaceuticals Inc stock price fell by -2.38% on the last day (Thursday, 25th Apr 2024) from $43.32 to $42.29. During the last trading day the stock fluctuated 4.34% from a day low at $41.05 to a day high of $42.83. The price has fallen in 7 of the last 10 days and is down by -11.95% for this period. Volume has increased on the last day by 173 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 573 thousand shares were bought and sold for approximately $24.24 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $42.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 22.94% during the next 3 months and, with a 90% probability hold a price between $51.82 and $63.90 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRNX Signals & Forecast

There are few to no technical positive signals at the moment. The Crinetics Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $43.32 and $43.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -11.95%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock

Crinetics Pharmaceuticals Inc finds support from accumulated volume at $40.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.78 between high and low, or 4.34%. For the last week, the stock has had daily average volatility of 4.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRNX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Crinetics Pharmaceuticals Inc to open at $42.06, and during the day (based on 14 day Average True Range), to move between $40.06 and $44.52, which gives a possible trading interval of +/-$2.23 (+/-5.26%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $42.76 (1.11%) than the support at $40.94 (3.19%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Crinetics Pharmaceuticals Inc will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.84. We will update the financials statements for Crinetics Pharmaceuticals Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.91% in the first trading day after earnings release.

Is Crinetics Pharmaceuticals Inc stock A Buy?

The Crinetics Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Crinetics Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.253 Sell Candidate Unchanged

Predicted Opening Price for Crinetics Pharmaceuticals Inc of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$42.06 ( 0.552%) $42.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRNX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.84 3.66 %
R2 43.16 2.05 %
R1 42.74 1.06 %
Current price: 42.29
Support S1 41.38 -2.16 %
S2 40.96 -3.15 %
S3 40.28 -4.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 47.62 12.60 %
R2 45.18 6.83 %
R1 42.76 1.11 %
Current price 42.29
Support S1 40.94 -3.19%
S2 38.93 -7.95%
S3 37.82 -10.57%

FAQ

What is the symbol for Crinetics Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Crinetics Pharmaceuticals Inc is CRNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Crinetics Pharmaceuticals Inc Stock?
The Crinetics Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Crinetics Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.

What's the current price of Crinetics Pharmaceuticals Inc Stock?
As of the end of day on the Apr 25, 2024, the price of an Crinetics Pharmaceuticals Inc (CRNX) share was $42.29.

What is the 52-week high and low for Crinetics Pharmaceuticals Inc Stock?
The 52-week high for Crinetics Pharmaceuticals Inc Stock is $49.58 and the 52-week low is $15.76.

What is the market capitalization of Crinetics Pharmaceuticals Inc Stock?
As of the Apr 25, 2024, the market capitalization of Crinetics Pharmaceuticals Inc is 3.296B.

When is the next earnings date for Crinetics Pharmaceuticals Inc?
The upcoming earnings date for Crinetics Pharmaceuticals Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c... CRNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT